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Aims: The European Society of cardiology (ESC) EURObservational Research Programme 
(EORP) European Endocarditis (EURO-ENDO) registry aims to study the care and outcomes of 
patients diagnosed with infective endocarditis and compare findings with recommendations 
from the 2015 ESC Clinical Practice Guidelines for the management of infective endocarditis 
and data from the 2001 Euro Heart Survey. 
Methods and results: Patients (n=3116) aged over 18 years with a diagnosis of infective 
endocarditis based on the ESC 2015 infective endocarditis diagnostic criteria were 
prospectively identified between January 1st, 2016 and March 31st, 2018. Individual patient 
data were collected across 156 centres and 40 countries. The primary end-point is all-cause 
mortality in hospital and at 1-year. Secondary end-points are 1-year morbidity (all-cause 
hospitalisation, any cardiac surgery and infective endocarditis relapse), the clinical, 
epidemiological, microbiological, and therapeutic characteristics of patients, the number and 
timing of non-invasive imaging techniques, and adherence to recommendations as stated in the 
2015 ESC Clinical Practice Guidelines for the management of infective endocarditis. 
Conclusion: EURO-ENDO is an international registry of care and outcomes of patients 
hospitalised with infective endocarditis which will provide insights into the contemporary 
profile and management of patients with this challenging disease. 
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Introduction   
 
Infective endocarditis (IE) is a lethal disease associated with not only high risk of death, but 
high rates of morbidity and healthcare expenditure (1-6). Despite improvements in diagnostic 
and therapeutic strategies, the incidence and severity of the disease remain unchanged – largely 
driven by the evolving epidemiological profile of patients as well as an increasing number with 
prosthetic or device related IE (7).  
In addition to temporal changes in patient characteristics (1, 7) over time, changes in key 
health service factors have occurred with potential impact on IE care and outcomes. These 
include the development of new diagnostic and therapeutic strategies for the management of 
IE (2), publication of the 2015 European Society of Cardiology (ESC) Clinical Practice 
Guidelines on the management of IE (8), the increasing recognition of the importance of the 
IE Team, and the availability of multi-modality imaging (8). Notably, it remains uncertain 
whether recommendations for the use of early surgery in patients with complicated IE have 
been widely adopted and whether this is associated with better or worse clinical outcomes. 
Equally, there are limited international data regarding adherence to (and impact of) changing 
recommendations for IE antibiotic prophylaxis. 
Given that the last major international survey of IE (the ESC Euro Heart Survey Programme 
dedicated to valvular heart disease) was performed in 2001 (9) with no comprehensive 
surveys since then, there is a compelling need to undertake a contemporary international 
investigation of the care and outcomes of IE. We therefore designed and implemented the 
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Aim of EURO-ENDO  
The aim of the EURO-ENDO registry is to undertake an international observational study to 
allow an up-to-date investigation of the care and outcomes of patients with IE. The primary 
objective of EURO-ENDO is to evaluate the outcome of patients diagnosed with Infective 
Endocarditis. The secondary objectives are to assess the current clinical, epidemiological, 
microbiological, therapeutic, and prognostic characteristics of IE in Europe, to assess the current 
practices of imaging in IE in Europe and in affiliated countries, to assess the degree of 
implementation of the ESC guidelines in practice, and to compare these current data with those 
obtained in the Euro Heart Survey. The wide geospatial coverage of EURO-ENDO will allow 
regional investigation of the management and outcomes of patients hospitalised with IE.   
 
Quality of care interventions 
By means of an electronic case record form, individual patient data were collected across 430 
unique data fields, including patient characteristics, clinical, biological, and microbiological 
data, the use of imaging procedures (and their results), antibiotic treatment and surgical 
interventions. Diagnostic methods for IE, antibiotic treatment, indications for and the use of 
surgery, and the frequency and type of patient follow-up were not pre-specified by the study 
protocol. 
 
Setting: University and non-university hospitals of any volume of activity within and 
beyond Europe were invited to join EURO-ENDO on a voluntary basis. All 57 ESC–member 
countries were invited to participate in EURO-ENDO, with centres within the countries being 
selected by a National Coordinator from the country. Participating centres were categorised 
by the European Association of Cardiovascular Imaging as either high level IE centres: high 
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management, imaging and surgical therapy or low volume centres (< 20 patients per year) 
without surgical capabilities, as self-reported by the participating centres. 
 
Population and consent:  From January 1st, 2016 to March 31st, 2018, centers were asked 
to include consecutive patients aged greater than 18 years over a 1-year follow-up period with 
a diagnosis of definite IE (or possible IE, considered and treated as IE) based on the ESC 2015 
infective endocarditis diagnostic criteria (8). Since all centres were asked to include patients 
during a 1-year period and to obtain 1-year follow-up for all these patients, the total duration 
of participation of each centre was 2 years, with end of follow-up of the study on March 31st, 
2019.  All participants received detailed written information concerning the study and provided 
signed informed consent. In total, 3116 index cases of IE from 156 centres across 40 countries 
were collected over the study period (Figures 1 and 2). 
 
Patient identification: Potential participants were identified from echocardiographic 
laboratories and hospitals treating patients with IE and given a unique study number.  
 
Start points: Any patient aged over 18 years and hospitalised between January 1st, 2016 to 
March 31st, 2018 with definite IE (or possible IE, considered and treated as IE) based on ESC 
2015 diagnostic criteria. 
 
Baseline and follow-up data: Baseline data included demographic data (site of inclusion, , 
age), patient history (previous IE, at-risk situation or procedure, history of cardiovascular and 
non-cardiac disease), clinical data (weight, height, date and timing of first signs and symptoms, 
temperature), previous cardiac or non-cardiac invasive intervention within the last 6 months 
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microbiological data (sedimentation rate, C-reactive protein, creatinine, haemoglobin, white 
blood cells, platelet count, blood cultures, serology), echocardiographic data (vegetation, 
abscess, valvular and perivalvular lesions, valve regurgitation or stenosis), other imaging 
techniques (CT scan, PET-CT, cerebral or cardiac MRI), treatment before admission and 
during hospitalization (including antibiotic therapy and all other treatments), complications 
under therapy (embolic event, infectious and haemodynamic complications, theoretical 
indications for surgery, in-hospital mortality), interventional treatments (valve surgery), and 1-
year complications (any hospitalisation, recurrence of IE and 1-year all-cause mortality)  
 
Data capture and storage:  Participant identifiable data were used to track subsequent 
clinical care and outcomes, with the identifiable data only residing on local centre computers. 
These data were then pseudonymised by means of a unique patient study code before electronic 
transmission via the ESC-EORP Data Entry System Security using SSL (Secure Sockets Layer) 
network encryption to a dedicated secure server (Microsoft SQL Server 2012 Database server) 
at the central data warehouse (The European Heart House, France). Data Collection Officers 
and local investigators at participating centres had access to electronic case report forms 
through secure login on the EORP website. Individual login names and passwords were 
distributed by the EORP team to the participating centres.  
 
Data quality Data quality was monitored by the ESC EORP EURO-ENDO administrative 
team. This included edit checks (for missing data, date chronology, numeric value ranges) 
and a Data Validation Plan listing all the checks carried out to ensure data consistency and 
adherence to the protocol, including missing data, consistency of the chronology in the dates 
and between the data of the different visits of the study (cross checks), and the numeric 
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Endpoints and linkages to other data: The primary end-points are in-hospital and 1-
year mortality. Secondary end-points are 1-year morbidity (any hospitalisation, any cardiac 
surgery, IE recurrence), clinical, epidemiological, microbiological and therapeutic 
characteristics, number and timing of non-invasive imaging techniques, and implementation 
of the 2015 ESC Clinical Practice Guidelines for the management of IE. In-patient data are 
collected from hospital medical records, and 1 year follow up data collected by contact with 
the participants via telephone calls and / or scheduled outpatient clinic appointments.  
 
Conclusion:  
To our knowledge, the ESC EORP EURO-ENDO registry is the most comprehensive and far 
reaching observational cohort of patients hospitalised with IE. The registry will describe the 
contemporary profile of patients admitted to hospital with IE, their investigations, treatment 
and clinical outcomes, and document how we care for patients with IE in the light of 
recommendations from the 2015 ESC Clinical Practice Guidelines for the management of IE. 
EURO-ENDO will, for example, offer insight into the implementation and impact of changing 
recommendations for the use of IE antibiotic prophylaxis. In addition, since EURO-ENDO 
registry finally includes patients from 4 continents countries, it represents a unique opportunity 
to compare the characteristics of IE across the world. Although it will unavoidably suffer the 
limitations of such a registry (voluntary nature, international reach, lack of a central/core 
laboratory to review echo images and microbiological samples), and given the paucity of 
randomized and large-scale observational data, the ESC EORP EURO-ENDO registry offers a 
unique opportunity to provide key information about the current care and outcomes of patients 
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Figure 1 Numbers of patients included in the ESC EORP EURO-ENDO registry according 
to participating country 
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